Efficacy, safety, and tolerability of dutasteride 0.5 mg once daily in male patients with male pattern hair loss: A randomized, double-blind, placebo-controlled, phase III study - Concepedia

Concepedia

Publication | Closed Access

Efficacy, safety, and tolerability of dutasteride 0.5 mg once daily in male patients with male pattern hair loss: A randomized, double-blind, placebo-controlled, phase III study

138

Citations

22

References

2010

Year

Hee Chul Eun, Ohsang Kwon, Je Ho Yeon, Hyo Seung Shin, Byung Yoon Kim, Byung In Ro, Han Kyong Cho, Woo‐Young Sim, Bark‐Lynn Lew, Won‐Soo Lee,

Journal of the American Academy of Dermatology

Phase Iii StudyMale PatientsDermatologyDutasteride 0.5

References

	Year	Citations

Page 1